Recently, Novavax, an “old school” recombinant protein-based COVID-19 vaccine, was granted emergency use authorization. Now antivaxxers are fear mongering about its use of “moth cells” and “tree bark.” That’s because to antivaxxers, it’s about the vaccines, not any specific technology.
James Lyons-Weiler has published an analysis claiming that Paul Thomas’ “Vaccine-Friendly Plan” is safer than the current CDC-recommended vaccine schedule because contains less aluminum. Unsurprisingly, The modeling behind the analysis is risibly incompetent. Same as it ever was.
“Nobel disease” is a term designed to describe whatever it is that drives some Nobel laureates to embrace pseudoscience or quackery later in their careers. One of its most prominent victims, Luc Montagnier, co-discoverer of the AIDS virus, recently demonstrated that he’s still suffering from Nobel disease when he laid down a barrage of antivaccine pseudoscience in Paris earlier this month.
Adjuvant therapy after surgery, such as chemotherapy, hormonal therapy, and radiation therapy, has contributed to a 39% decrease in breast cancer mortality since 1989. Unfortunately, a significant number of women decline evidence-based adjuvant therapy. A recent study suggests that distrust of the medical system plays a significant role in such refusal.
Over the last couple of days I noted a disturbance in the antivaccine force, another study claimed to be slam dunk evidence that aluminum adjuvants in vaccines cause autism. It’s not. Also, a word to antivaxers challenging Orac to look at this study: Be very careful what you wish for…
